Avelo
Avelo develops the AveloMask, a breath aerosol collector designed to capture viruses and bacteria from the respiratory tract for molecular testing. The device enables non-invasive sampling for patients with respiratory infections such as tuberculosis and pneumonia, serving as an alternative to invasive or unreliable traditional methods. The system works with existing diagnostic tests to help clinicians differentiate between viral and bacterial infections and guide antibiotic treatment.
Visit websiteSchlieren, Switzerland
Healthtech
Medical Devices
Diagnostics
Funding summary
- Total raised
- €2.4M
- Funding rounds
- 2
Investors in Avelo
Investors on record for Avelo. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Avelo?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors